Johnson & Johnson Net Acquisitions/Divestitures 2010-2025 | JNJ
Johnson & Johnson annual/quarterly net acquisitions/divestitures history and growth rate from 2010 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
- Johnson & Johnson net acquisitions/divestitures for the quarter ending March 31, 2025 were $0M, a 100% decline year-over-year.
- Johnson & Johnson net acquisitions/divestitures for the twelve months ending March 31, 2025 were $-45.098B, a 2390.23% increase year-over-year.
- Johnson & Johnson annual net acquisitions/divestitures for 2024 were $-15.146B, a 0% decline from 2023.
- Johnson & Johnson annual net acquisitions/divestitures for 2023 were $0B, a 100% decline from 2022.
- Johnson & Johnson annual net acquisitions/divestitures for 2022 were $-17.652B, a 29320% increase from 2021.
Johnson & Johnson Annual Net Acquisitions/Divestitures
(Millions of US $) |
| 2024 |
$-15,146 |
| 2023 |
$N/A |
| 2022 |
$-17,652 |
| 2021 |
$-60 |
| 2020 |
$-7,323 |
| 2019 |
$-5,810 |
| 2018 |
$-899 |
| 2017 |
$-35,151 |
| 2016 |
$-4,509 |
| 2015 |
$-954 |
| 2014 |
$-2,129 |
| 2013 |
$-835 |
| 2012 |
$-4,486 |
| 2011 |
$-2,797 |
| 2010 |
$-1,269 |
| 2009 |
$-2,470 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharma |
$371.642B |
$88.821B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
